NPPA and hydrops fetalis: Finally, a pre-specified secondary analysis of the PROVE-HF study showed that the initiation of treatment with sacubitril/valsartan produced a rapid (before 14 days) and significant increase in atrial natriuretic peptide (ANP) correlated with a subsequent increase in urinary cGMP (50).